Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription 29.06.2026 1 Am J Pathol 1 Biochem Biophys Res Commun 7 BMC Cancer 20 BMC Gastroenterol 1 Br J Surg 1 Cancer Res 2 Dig Dis Sci 2 Endoscopy 1 Eur J Pediatr 3 Eur Radiol 3 Gastroenterology 1 Gut 2 Int J Cancer 2 J Gastroenterol 3 J Gastroenterol Hepatol 5 J Hepatol 2 J Pediatr Surg 1 Oncogene 1 PLoS Comput Biol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Pathol

1. DAY LZ, Hernandez-Tejero M, Sakrikar NJ, Mokbul MI, et al
   Unbiased Spatial Proteomics Uncovers Hepatic In Situ Regulation in Alcohol-Associated Hepatitis.
   Am J Pathol. 2026 Jun 19:S0002-9440(26)00169.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. TICE AL, Murphy RD, Laudato JA, Tangen AR, et al
   Impact of alcohol cessation on hepatic metabolic signaling during cancer cachexia.
   Biochem Biophys Res Commun. 2026;829:154176.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. YANG Y, Yang H, Du Y, Hou S, et al
   Prognostic value of combined FIB-4 and AFP in predicting survival after hepatectomy for hepatocellular carcinoma: a multicenter cohort study.
   BMC Cancer. 2026 Jun 20. doi: 10.1186/s12885-026-16360.
   PubMed         Abstract available
   
   
4. MA L, Fan L, Luo X, Huang Z, et al
   Exploring the relationship between potential hepatotoxicity and novel hormonal therapies in prostate cancer: a systematic review and meta-analysis.
   BMC Cancer. 2026 Jun 23. doi: 10.1186/s12885-026-16339.
   PubMed         Abstract available
   
   
5. CHEN M, Zhao Z, Zhou L, Kong C, et al
   MRI-based deep learning model for early TACE response prediction in HCC: multicenter validation with biological insights.
   BMC Cancer. 2025;25:1810.
   PubMed         Abstract available
   
   
6. ZHAO YM, Xie SS, Wang J, Hu ZD, et al
   VETC predicting model based on CE-CT can predict prognosis and assisting treatment plan for solitary HCC: better together with radiomics.
   BMC Cancer. 2025;25:1033.
   PubMed         Abstract available
   
   
7. WANG Q, Zhang J, Wang H, Na L, et al
   PCBP1-AS1 facilitates liver metastasis in pancreatic cancer by modulating miR-125b-5p in Tumor-derived exosomes to target TNFAIP3.
   BMC Cancer. 2025;25:1553.
   PubMed         Abstract available
   
   
8. JUMAI N, Chen L, Lin X, He Q, et al
   Identification of gastroenteropancreatic neuroendocrine tumor patients with high liver tumor burden based on clinicopathological features.
   BMC Cancer. 2025;25:1217.
   PubMed         Abstract available
   
   
9. NAKAYAMA T, Suzuki K, Mitsutake N
   Calorie restriction in radiation-exposed mice affects the expression of autophagy-related protein p62.
   BMC Cancer. 2025;25:1388.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

10. HAGIWARA S, Matsubara T, Omaru N, Okai N, et al
    Curative treatment is feasible for recurrent hepatocellular carcinoma regardless of recurrence pattern after hepatitis C virus eradication with interferon-free direct-acting antiviral therapy.
    BMC Gastroenterol. 2026 Jun 22. doi: 10.1186/s12876-026-05006.
    PubMed         Abstract available
    
    
11. AN J, Li X, Fu Y, Xie H, et al
    Causal effects of cholelithiasis on hepatopancreatobiliary diseases: a multi-cohort Mendelian randomization study.
    BMC Gastroenterol. 2026 Jun 25. doi: 10.1186/s12876-026-05033.
    PubMed         Abstract available
    
    
12. MOHANTY A, Stead AE, Telep LE, Singer AW, et al
    Hepatocellular carcinoma risk reduction associated with antiviral treatment in patients with noncirrhotic chronic hepatitis B: a systematic literature review and comparative meta-analysis.
    BMC Gastroenterol. 2026 Jun 26. doi: 10.1186/s12876-026-04996.
    PubMed         Abstract available
    
    
13. ZHAO J, Meng Y, Jiang Z, Li Z, et al
    Development and validation of a nomogram to predict recurrence after hepatectomy in overweight patients with hepatocellular carcinoma: a retrospective cohort study.
    BMC Gastroenterol. 2026 Jun 26. doi: 10.1186/s12876-026-04995.
    PubMed         Abstract available
    
    
14. LU N, Yuan C, Li J, Sun B, et al
    Diagnosis and treatment of hemothorax following local ablation in patients with primary liver cancer.
    BMC Gastroenterol. 2025;25:489.
    PubMed         Abstract available
    
    
15. TRAN H, Caruso S, Mazialivoua AL, Fargeat C, et al
    Prevalence of advanced liver fibrosis in the general population of the Paris region according to FIB-4 score and liver risk score.
    BMC Gastroenterol. 2025;25:454.
    PubMed         Abstract available
    
    
16. ZHOU G, Han W, Luan J, Ma B, et al
    Prognostic value of ALBI score for all-cause mortality in metabolic associated fatty liver disease patients: a cohort study from NHANES 2003-2018.
    BMC Gastroenterol. 2025;25:561.
    PubMed         Abstract available
    
    
17. FU C, Gong Y, Gao X, Li Y, et al
    Association between the ApoB/ApoA1 ratio and both the severity and mortality of metabolic dysfunction-associated fatty liver disease.
    BMC Gastroenterol. 2025;25:650.
    PubMed         Abstract available
    
    
18. JIN P, Li N, Liu C, Sheng D, et al
    A chitinase-3-like protein-1-based nomogram for identification of significant liver fibrosis in the general population.
    BMC Gastroenterol. 2025;25:688.
    PubMed         Abstract available
    
    
19. CHEN Z, Yu J, Wang Y, Zhang D, et al
    Associations of urinary iodine concentration (UIC) with Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) among non-diabetic population: analysis of the NHANES 2017-2020.
    BMC Gastroenterol. 2025;25:705.
    PubMed         Abstract available
    
    
20. MSAGATI F, Alphonce B, Sindato E
    Prevalence, demographic characteristics and clinical profile of metabolic dysfunction-associated fatty liver disease among adult patients attending tertiary hospitals in Dodoma, Tanzania. a cross-sectional study.
    BMC Gastroenterol. 2025;25:734.
    PubMed         Abstract available
    
    
21. TAMILWANAN S, Aziz Z, Rong LY, Bitar AN, et al
    Efficacy of GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists in managing MALFD: a meta-analysis of randomized controlled trials.
    BMC Gastroenterol. 2025;25:765.
    PubMed         Abstract available
    
    
22. TAMURA A, Fujita K, Ieko Y, Suzuki Y, et al
    Establishment of normative spleen volume in a Japanese cohort using automated CT segmentation: diagnostic implications for liver fibrosis.
    BMC Gastroenterol. 2025;25:775.
    PubMed         Abstract available
    
    
23. NEDUNCHEZHIAN S, Shetty A, Bhat G, Shetty S, et al
    Role of procalcitonin in identifying systemic inflammatory response syndrome and sepsis in acute-on-chronic liver failure and its impact on survival.
    BMC Gastroenterol. 2025;25:797.
    PubMed         Abstract available
    
    
24. ZHOU H, Huang H, Zhao H, Pang N, et al
    The albumin-to-creatinine ratio predicts and explores potential mediation of mortality in metabolic dysfunction-associated steatotic liver disease in U.S. adults: evidence from NHANES 1999-2018.
    BMC Gastroenterol. 2025;25:820.
    PubMed         Abstract available
    
    
25. WANG XS, Zheng HB, Zhu HH, Feng JG, et al
    A retrospective study on the efficacy of ex vivo liver resection combined with autologous liver transplantation in treating advanced alveolar echinococcosis at high altitude.
    BMC Gastroenterol. 2025;26:48.
    PubMed         Abstract available
    
    
26. YOUSEFI Z, Rajabi R, Karima S, Nourbakhsh M, et al
    Protective anti-fibrotic effect of liraglutide and Pirfenidone combination therapy on liver fibrosis in rats: effects on autophagy and NLRP3 inflammasome.
    BMC Gastroenterol. 2025;26:57.
    PubMed         Abstract available
    
    
27. SWAI HJ, Paulo DG, Uiso E, Komba E, et al
    Predictors of 1-month and 3-month readmission among patients with decompensated advanced chronic liver disease admitted at a tertiary hospital in Tanzania: a hospital-based prospective cohort study.
    BMC Gastroenterol. 2026;26:73.
    PubMed         Abstract available
    
    
28. ZHENG J, Xie D, Nong Y, Jia K, et al
    Association of the C-reactive protein-triglyceride-glucose index with liver disease risk: findings from a nationwide Chinese cohort.
    BMC Gastroenterol. 2026;26:87.
    PubMed         Abstract available
    
    
29. ALGHAMDI S, Raptis DA, Alomar I, Alotaibi W, et al
    Liver transplantation for Wilson disease: a spectrum from acute liver failure to Neuro-Wilson.
    BMC Gastroenterol. 2026;26:382.
    PubMed         Abstract available
    
    

    
    Br J Surg

30. SOBNACH S, Bayadsi H, Kotze U, Nystrom H, et al
    Global disparities in hepatocellular carcinoma outcomes: multicentre study.
    Br J Surg. 2026 Jun 22:znag079. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Cancer Res

31. GU H, Li F, Chen Y, Zhang M, et al
    EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.
    Cancer Res. 2026 Jun 22. doi: 10.1158/0008-5472.CAN-25-4582.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

32. LI X, Wang Y, Shen C, Gu R, et al
    IL-17/IL-17RA Axis Facilitates Immune Evasion in Hepatocellular Carcinoma by Upregulating PD-L1 via the NF-kappaB Pathway.
    Dig Dis Sci. 2026 Jun 24. doi: 10.1007/s10620-026-10076.
    PubMed         Abstract available
    
    
33. SHASTRI A, Taneja S
    Tuberculosis in Cirrhosis: A Diagnostic and Therapeutic Challenge.
    Dig Dis Sci. 2026 Jun 20. doi: 10.1007/s10620-026-10068.
    PubMed         Abstract available
    
    

    
    Endoscopy

34. OGURA T, Bessho K, Nakamura J, Nguyen Trong N, et al
    Tri-side-by-side stent deployment for hepatic hilar obstruction using fully covered self-expandable metal stents with a spiral-grooved outer surface.
    Endoscopy. 2026 Jun 24. doi: 10.1055/a-2888-0596.
    PubMed        
    
    
35. SUMIYA H, Koshita S, Kanno Y, Ogawa T, et al
    A rescue technique for segmental cholangitis after metallic stent placement in endoscopic ultrasound-guided hepaticogastrostomy.
    Endoscopy. 2026 Jun 23. doi: 10.1055/a-2883-0988.
    PubMed        
    
    

    
    Eur J Pediatr

36. ELHADY MA, Kaddah M, Marzouk A, Mogahed EA, et al
    Assessment of hepatic fibrosis in Egyptian children and adolescents with beta thalassemia major: a single center study.
    Eur J Pediatr. 2026;185:533.
    PubMed         Abstract available
    
    

    
    Eur Radiol

37. TAKAYAMA H, Ichikawa T, Yokota T, Fukushima Y, et al
    Arterial phase CT improves detection of colorectal liver metastases: evaluation of the downslope injection method.
    Eur Radiol. 2026;36:5392-5400.
    PubMed         Abstract available
    
    
38. JIANG B, Li Y, Fei X, Zhu L, et al
    The application of Doppler ultrasound in evaluating angioplasty outcomes and predicting recurrence in Budd-Chiari syndrome.
    Eur Radiol. 2026;36:5290-5302.
    PubMed         Abstract available
    
    
39. MULLER L, Jorg T, Grunz JP, Graafen D, et al
    Photon-counting detector CT with iodine quantification: improved distinction between bland and neoplastic portal vein thrombosis.
    Eur Radiol. 2026;36:5380-5391.
    PubMed         Abstract available
    
    

    
    Gastroenterology

40. KANWAL F, Bril F, Wong VW, Adams LA, et al
    Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Gastroenterology. 2026;171:164-183.
    PubMed         Abstract available
    
    
41. KATO S, Hikita H, Takehara T
    Reply to "Critical Appraisal of the Integrin alphaV-YAP-CTGF Axis in Congestive Hepatopathy".
    Gastroenterology. 2026 Jun 26:S0016-5085(26)06989.
    PubMed        
    
    
42. SUN J, Guan Z, Liu Y
    Critical Appraisal of the Integrin alphaV-YAP-CTGF Axis in Congestive Hepatopathy.
    Gastroenterology. 2026 Jun 26:S0016-5085(26)06988.
    PubMed        
    
    

    
    Gut

43. LU G, Du R, Wan Y, Dong J, et al
    Targeting NEK9 synergises with immunotherapy in hepatocellular carcinoma by remodelling the immunosuppressive microenvironment.
    Gut. 2026 Jun 25:gutjnl-2026-338449. doi: 10.1136/gutjnl-2026-338449.
    PubMed         Abstract available
    
    

    
    Int J Cancer

44. LIU D, Xu B, Huang D, Sun Z, et al
    Liver metastasis ablation combined with PD-1 inhibitors improves immunotherapy efficacy: A multicenter cohort study.
    Int J Cancer. 2026;159:951-959.
    PubMed         Abstract available
    
    
45. HERNANDEZ BY, Zhu X, Macatugal E, Nagata M, et al
    Cyanotoxin exposure as a novel risk factor for liver fibrosis and steatosis.
    Int J Cancer. 2026;159:864-875.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

46. YASUURA N, Suda G, Ohara M, Yokoyama D, et al
    Alcohol involvement may modify the association between previous hepatitis B virus infection and hepatocellular carcinoma risk in steatotic liver disease.
    J Gastroenterol. 2026 Jun 26. doi: 10.1007/s00535-026-02473.
    PubMed         Abstract available
    
    
47. SEKO Y, Yamaguchi K
    Management of MASLD/MASH: challenges, innovations, and the future of patient-centered care in Japan.
    J Gastroenterol. 2026;61:880-908.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

48. ULLAH W, Ashok K, Antar AS
    Comments on "Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in Lowering the Risk of Hepatocellular Carcinoma Development in Patients With Chronic Hepatitis B".
    J Gastroenterol Hepatol. 2026 Jun 26. doi: 10.1111/jgh.70539.
    PubMed        
    
    
49. KHAN SA, Bharadwaj HR, Sharma A, Dhali A, et al
    Artificial Intelligence in Surveillance of Hepatocellular Carcinoma: Hype or Reality?
    J Gastroenterol Hepatol. 2026 Jun 25. doi: 10.1111/jgh.70536.
    PubMed        
    
    
50. CHEN J, Cai X
    Methodological Considerations for Sector-Based MRI Radiomics in Predicting Post-TACE Recurrence Location in Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2026 Jun 19. doi: 10.1111/jgh.70514.
    PubMed        
    
    

    
    J Hepatol

51. ENGEBRETSEN E
    Sustainable hepatology beyond carbon.
    J Hepatol. 2026 Jun 24:S0168-8278(26)02632-2. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
52. FALLOWFIELD JA, Ramachandran P, Kendall TJ
    Regression of liver cirrhosis.
    J Hepatol. 2026 Jun 24:S0168-8278(26)02644-9. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
53. ROUSIAN M, Alessandris R, Schleimer L, Kalvin H, et al
    Hepatic artery infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: Pooled individual patient-level analysis of four clinical trials.
    J Hepatol. 2026 Jun 22:S0168-8278(26)02655-3. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
54. MARTIN-GRAU M, Kamstra JH, Hyotylainen T, Oresic M, et al
    The Hepato-Exposome Axis: How Endocrine Disruptors Hijack Liver Receptors to Drive MASLD.
    J Hepatol. 2026 Jun 22:S0168-8278(26)02653-X. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
55. KALAL CR, Gupta P
    Rifaximin and the DCA-serotonin axis in cirrhotic portal hypertension: how much of the benefit is bile-acid specific?
    J Hepatol. 2026 Jun 20:S0168-8278(26)02650-4. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    

    
    J Pediatr Surg

56. WANG B, Xia X, Wang Y, Tang C, et al
    Comparison of robotic and laparoscopic liver resection for pediatric liver tumor: A multicenter study.
    J Pediatr Surg. 2026;61:163147.
    PubMed         Abstract available
    
    
57. ZIOGAS IA, Kakos CD, Kokkinakis S, Khomiak A, et al
    Systematic review and national cancer database analysis of minimally invasive liver surgery in children.
    J Pediatr Surg. 2026;61:163079.
    PubMed         Abstract available
    
    

    
    Oncogene

58. XIAO Y, He Z, Al-Subari MH, Zhang H, et al
    MOV10 suppresses circRNA biogenesis by disrupting reverse complementary matches structure to drive hepatocarcinogenesis.
    Oncogene. 2026 Jun 21. doi: 10.1038/s41388-026-03869.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

59. SONG Y, Ning Y, Li M, Lan J, et al
    A lactylation- and autophagy-associated prognostic signature reveals LSEC-derived CLEC3B as a novel mediator of hepatocellular carcinoma suppression.
    PLoS Comput Biol. 2026;22:e1014426.
    PubMed         Abstract available
    
    

    
    PLoS One

60. ZHU X, Lin C, Liu X, Huang Z, et al
    Association between Red Cell Distribution Width (RDW)-related inflammatory biomarkers and prognosis in ICU Cirrhosis patients: Evidence from the MIMIC-IV.
    PLoS One. 2026;21:e0352023.
    PubMed         Abstract available
    
    
61. MESSER EK, Fischer J, Herta T, Boehlig A, et al
    Stage-dependent dynamics of Apolipoprotein C3 across the spectrum of MASLD.
    PLoS One. 2026;21:e0349666.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum